-
Clinical research results for Kelun-Biotech’s TROP2 ADC sacituzumab tirumotecan (sac-TMT) published in Nature Medicine, a top international medical journal
12 Apr 2025 10:02 GMT
… 47;PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “ … May 2022, the Company licensed the exclusive rights to MSD … MSD.
About Kelun-Biotech
Kelun-Biotech(6990.HK)is a … research-results-for-kelun-biotechs-trop2-adc-sacituzumab-tirumotecan …
-
ABL Bio lands $2.8 licensing agreement with GSK
11 Apr 2025 15:47 GMT
… Inc., a South Korean biotech company, will license out its proprietary blood …
-
Why This Chinese Biotech Could Be Pharma's DeepSeek
11 Apr 2025 14:37 GMT
The drugmaker's shares rallied after the release of its strong annual report, up by a cumulative 18% over the next three trading days
Key Takeaways:
Akeso's drug sales rose 25% last year to just above 2 billion yuan, setting a new high for the …
-
Vir Biotechnology, Inc. (VIR): Among Stocks Under $10 that Will Triple
11 Apr 2025 01:42 GMT
… Of Hedge Funds: 31 Vir Biotechnology, Inc. (NASDAQ:VIR) develops treatments … efficient. Despite revenue declines, Vir Biotechnology, Inc. (NASDAQ:VIR) showed operational … strategic investments like the Sanofi licensing deal. Still, the company’s …
-
Biotech Bright Spots: 3 Stocks Powering Through Q2 Volatility
10 Apr 2025 17:53 GMT
With tariffs sending markets reeling in the first days of the second quarter, investors with cash to spend might be looking for an opportunity. While it’s true that some of the biggest firms in the world started April with major share price discounts, …
-
Quantum BioPharma Licensee Celly Nutrition Announces Landmark Partnership with the Asian American Trade Associations Council (AATAC) to Expand Retail Availability of its Alcohol Detox Beverage unbuzzd™
10 Apr 2025 11:30 GMT
… the “Company”), today announced its licensee – Celly Nutrition Corporation (“Celly Nutrition … portfolio of innovative assets and biotech solutions for the treatment of …
-
DuChemBio inks Taiwan licensing deal for Parkinson’s diagnostic 18F-FP-CIT
10 Apr 2025 07:16 GMT
… an exclusive licensing deal with Taiwan’s PET Pharm Biotech (PPhBio) to …
-
ABL Bio held back its top Alzheimer’s targets. GSK still signed a $2.7 bil. licensing deal.
10 Apr 2025 01:19 GMT
… the largest licensing deals in Korean biotech history—granting … hyaluronidase platform into a licensing machine.
“In this … players who could realistically license the platform, Lee estimated … partnership with U.S. biotech Ionis Pharmaceuticals. Results have …
-
Amid Trade Tensions, Commission Warns China is ‘Dangerously Close’ to Overtaking US Biotech
09 Apr 2025 14:40 GMT
… National Security Commission on Emerging Biotechnology (NSCEB) found that over the … from trade group Biotechnology Innovation Organization, 79% of biotech companies have at … flagged the “little clarity” regarding licensing deals with Chinese companies—a …
-
Report says US biotech needs $15bn support to fend off China
09 Apr 2025 11:13 GMT
… National Security Commission on Emerging Biotechnology (NSCEB), which warns that … the rising number of licensing deals involving Chinese biotech intellectual property (IP … and global influence."
"Biotechnology can ensure our warfighters continue …